" A NOVEL G PROTEIN-COUPLED RECEPTOR, GAVE 3"
Application 2025/CHENP/2003 published 2006-01-06, filed 2003-12-19
Novel GAVE3 polypeptides, proteins and nucleic acid molecules are provided. In addition to isolated, full-length GAVE3 proteins, isolated GAVE3 fusion proteins, antigenic peptides and anti-GAVE3 antibodies are taught. GAVE3, recombinant expression vectors, host cells into that the expression vectors have been introduced and non-human transgenic animals in that a GAVE3 gene has been introduced or disrupted are taught. Diagnostic, screening and therapeutic methods utilizing compositions of the invention also are provided.
Applicant
AVENTIS PHARMACEUTICALS INC
300 Somerset Corporate Boulevard, Bridgewater, NJ 08807-2854,USA.
Inventor
International Info
Classification: C12N
Publication Number: PCT/US02/19490
Priority Information
09/886,041 USA. 2001-06-22